NCT06254495 2026-03-16A Safety Study of PF-08046044/SGN-35C in Adults With Advanced CancersSeagen Inc.Phase 1 Active not recruiting57 enrolled
NCT05403450 2026-02-23A Study of Tolinapant in Combination With Oral Decitabine/Cedazuridine and Oral Decitabine/Cedazuridine Alone in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma (R/R PTCL)Taiho Oncology, Inc.Phase 1 Active not recruiting33 enrolled
NCT06870487 2026-02-19A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced CancersPfizerPhase 1 Active not recruiting6 enrolled
NCT05377827 2025-04-29Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic MalignanciesWashington University School of MedicinePhase 1 Active not recruiting6 enrolled
NCT04072458 2025-02-24A Clinical Trial of BP1002 in Patients With Advanced Lymphoid MalignanciesBio-Path Holdings, Inc.Phase 1 Active not recruiting30 enrolled
NCT02732275 2025-02-07DS-3201b in Participants With LymphomasDaiichi SankyoPhase 1 Active not recruiting100 enrolled